Response
Franke et al indicate that 3D echocardiographic imaging of the left ventricular outflow tract (LVOT) area is another suitable approach for assessing the hemodynamic relevance of hypertrophic obstructive cardiomyopathy (HOCM). As stated in our article, 1 there are studies on the use of transesophageal 3D echocardiography for both diagnosis and follow-up after intervention, and we are pleased to observe that the results obtained by the authors 2 are in the same range as those we report.
However, we do not concur with the other statements of Franke et al. The timepoint in our study was not preselected but rather was defined by flow physiology. As described in Methods, we determined the end-systolic phase by flow measurements using phase-contrast sequences. Thus, we individually verified the adequate timing of our sequence. Furthermore, we took great care to detect the narrowest part of the LVOT by analyzing images obtained at that time from a set of Ն3 slices.
We also would like to more precisely describe the area we measured. As can be seen in Figure 1 in our article, 1 we measured the entire LVOT area, not only the turbulent vena contracta flow. The anatomic borders, including the anterior mitral valve leaflet, were readily detectable in all studies. We have subsequently obtained preliminary evidence that MRIderived LVOT area measurements may even be helpful in differentiating asymptomatic HOCM from other diseases with similar left ventricular hypertrophy. There is variability in the measurements, and the sample size is still limited. Nevertheless, we believe that the excellent anatomic depiction offered by MRI provides great diagnostic power. This power is further increased by the outstanding ability of MRI to visualize pathology-related morphology and function before and after therapeutic interventions.
